Rims2 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
{{infobox
|boxstyle = infobox-gene
|title = RIMS2 Gene
|image =
|caption =
|gene_name = RIMS2
|full_name = Regulating Synaptic Membrane Exocytosis 2
|chromosome = 7
|locus = 7q31.3
|ncbi_gene_id = 9698
|omim_id = 607351
|ensembl = ENSG00000155380
|uniprot = Q9UQ26
|diseases = Parkinson's Disease, Intellectual Disability, Autism Spectrum Disorder
|inheritance = Autosomal Dominant
}}
RIMS2 (Regulating Synaptic Membrane Exocytosis 2), also known as RIM2, is a critical presynaptic protein that regulates synaptic vesicle docking, priming, and fusion. As a member of the RIM family, RIMS2 plays essential roles in:
RIMS2 interacts with multiple proteins including:
RIMS2 has been implicated in PD pathogenesis. Studies show RIMS2 expression is altered in PD brain tissue, and genetic variants may affect dopaminergic neurotransmission. RIMS2 plays important roles in:
RIMS2 mutations have been identified in patients with intellectual disability and developmental delay. The synaptic plasticity functions of RIMS2 are crucial for cognitive development.
RIMS2 has been nominated as an ASD risk gene based on exome sequencing studies. Altered synaptic vesicle release dynamics may contribute to ASD pathophysiology.
RIMS2 is expressed throughout the brain with highest levels in:
Expression pattern is consistent with roles in excitatory synaptic transmission throughout the CNS.
RIMS2 is a potential therapeutic target for:
The study of Rims2 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.